Your browser doesn't support javascript.
loading
PHF2 histone demethylase acts as a tumor suppressor in association with p53 in cancer.
Lee, K-H; Park, J-W; Sung, H-S; Choi, Y-J; Kim, W H; Lee, H S; Chung, H-J; Shin, H-W; Cho, C-H; Kim, T-Y; Li, S-H; Youn, H-D; Kim, S J; Chun, Y-S.
Afiliação
  • Lee KH; Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Park JW; 1] Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul, Republic of Korea [2] Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Sung HS; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Choi YJ; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Kim WH; Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Lee HS; Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Chung HJ; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Shin HW; Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Cho CH; 1] Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul, Republic of Korea [2] Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Kim TY; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Li SH; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Youn HD; 1] Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul, Republic of Korea [2] Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Kim SJ; 1] Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul, Republic of Korea [2] Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea [3] Department of Physiology, Seoul National University College of Medicine, S
  • Chun YS; 1] Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul, Republic of Korea [2] Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea [3] Department of Physiology, Seoul National University College of Medicine, S
Oncogene ; 34(22): 2897-909, 2015 May 28.
Article em En | MEDLINE | ID: mdl-25043306
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Genes Supressores de Tumor / Proteína Supressora de Tumor p53 / Proteínas de Homeodomínio / Neoplasias Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Oncogene Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Genes Supressores de Tumor / Proteína Supressora de Tumor p53 / Proteínas de Homeodomínio / Neoplasias Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Oncogene Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article